Literature DB >> 31628841

The Value of Hyperimmune Globulin in Pregnancies Complicated by Cytomegalovirus Infection: A Continuing Saga.

Mark R Schleiss1.   

Abstract

Entities:  

Keywords:  CMV glycoproteins; CMV hyperimmune globulin; CMV vaccines; congenital CMV; placenta

Year:  2020        PMID: 31628841      PMCID: PMC7486836          DOI: 10.1093/cid/ciz1036

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  18 in total

1.  All Cytomegalovirus-infected Children Need Hearing and Neurologic Follow-up.

Authors:  Albert Park; Sara Doutre; Mark R Schleiss; Angela Shoup
Journal:  Clin Infect Dis       Date:  2020-01-01       Impact factor: 9.079

Review 2.  Systematic review of the birth prevalence of congenital cytomegalovirus infection in developing countries.

Authors:  Tatiana M Lanzieri; Sheila C Dollard; Stephanie R Bialek; Scott D Grosse
Journal:  Int J Infect Dis       Date:  2014-03-12       Impact factor: 3.623

3.  Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration.

Authors:  K O Kagan; M Enders; M S Schampera; E Baeumel; M Hoopmann; A Geipel; C Berg; R Goelz; L De Catte; D Wallwiener; S Brucker; S P Adler; G Jahn; K Hamprecht
Journal:  Ultrasound Obstet Gynecol       Date:  2019-02-08       Impact factor: 7.299

Review 4.  Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation.

Authors:  Guy El Helou; Raymund R Razonable
Journal:  Expert Opin Drug Saf       Date:  2019-09-06       Impact factor: 4.250

5.  Case report on early treatment with valaciclovir after maternal primary cytomegalovirus infection.

Authors:  Camille Codaccioni; Christelle Vauloup-Fellous; Emmanuelle Letamendia; Julien Saada; Alexandra Benachi; Alexandre J Vivanti
Journal:  J Gynecol Obstet Hum Reprod       Date:  2019-01-08

6.  Placental enlargement in women with primary maternal cytomegalovirus infection is associated with fetal and neonatal disease.

Authors:  Renato La Torre; Giovanni Nigro; Manuela Mazzocco; Al M Best; Stuart P Adler
Journal:  Clin Infect Dis       Date:  2006-09-06       Impact factor: 9.079

Review 7.  Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection.

Authors:  Aileen Kenneson; Michael J Cannon
Journal:  Rev Med Virol       Date:  2007 Jul-Aug       Impact factor: 6.989

Review 8.  Evaluation and management of cytomegalovirus-associated congenital hearing loss.

Authors:  Allison M Dobbie
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2017-10       Impact factor: 2.064

Review 9.  Neuropathogenesis of congenital cytomegalovirus infection: disease mechanisms and prospects for intervention.

Authors:  Maxim C-J Cheeran; James R Lokensgard; Mark R Schleiss
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

10.  Sequelae of Congenital Cytomegalovirus Following Maternal Primary Infections Are Limited to Those Acquired in the First Trimester of Pregnancy.

Authors:  Valentine Faure-Bardon; Jean-François Magny; Marine Parodi; Sophie Couderc; Patricia Garcia; Anne-Marie Maillotte; Melinda Benard; Didier Pinquier; Dominique Astruc; Hugues Patural; Patrick Pladys; Sophie Parat; Bernard Guillois; Armelle Garenne; Laurence Bussières; Tiffany Guilleminot; Julien Stirnemann; Idir Ghout; Yves Ville; Marianne Leruez-Ville
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 9.079

View more
  3 in total

1.  Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH.

Authors:  Andrea J Parsons; Sabrina I Ophir; J Andrew Duty; Thomas A Kraus; Kathryn R Stein; Thomas M Moran; Domenico Tortorella
Journal:  Commun Biol       Date:  2022-04-25

2.  Amniotic fluid biomarkers predict the severity of congenital cytomegalovirus infection.

Authors:  Olesya Vorontsov; Lorinne Levitt; Daniele Lilleri; Gilad W Vainer; Orit Kaplan; Licita Schreiber; Alessia Arossa; Arseno Spinillo; Milena Furione; Or Alfi; Esther Oiknine-Djian; Meital Kupervaser; Yuval Nevo; Sharona Elgavish; Moran Yassour; Maurizio Zavattoni; Tali Bdolah-Abram; Fausto Baldanti; Miriam Geal-Dor; Zichria Zakay-Rones; Nili Yanay; Simcha Yagel; Amos Panet; Dana G Wolf
Journal:  J Clin Invest       Date:  2022-06-01       Impact factor: 19.456

Review 3.  SARS-CoV-2: Is it the newest spark in the TORCH?

Authors:  Kathleen M Muldoon; Karen B Fowler; Megan H Pesch; Mark R Schleiss
Journal:  J Clin Virol       Date:  2020-04-14       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.